Clinical Trial

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a prospective, single arm, single center study to evaluate the efficacy and safety of Duvelisib combined with Chidamide in the treatment of newly diagnosed peripheral T-cell lymphoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-27.
Trial Details
NCT Number NCT05976997
Lead Sponsor Liling Zhang
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions Newly Diagnosed Peripheral T-cell Lymphoma
Enrollment 36 participants
Start Date 2023-05-08
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-18